208 related articles for article (PubMed ID: 16520989)
21. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
[TBL] [Abstract][Full Text] [Related]
22. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
[TBL] [Abstract][Full Text] [Related]
23. Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia.
Weng Q; Wang D; Guo P; Fang L; Hu Y; He Q; Yang B
Eur J Pharmacol; 2008 Mar; 581(3):262-9. PubMed ID: 18215659
[TBL] [Abstract][Full Text] [Related]
24. Anti-proliferative activity of fenretinide in human hepatoma cells in vitro and in vivo.
Shentu J; Zhang B; Fan L; He Q; Yang B; Chen Z
Anticancer Drugs; 2007 Jan; 18(1):47-53. PubMed ID: 17159502
[TBL] [Abstract][Full Text] [Related]
25. MZ3 induces apoptosis in human leukemia cells.
Fang L; He Q; Hu Y; Yang B
Cancer Chemother Pharmacol; 2007 Feb; 59(3):397-405. PubMed ID: 16900371
[TBL] [Abstract][Full Text] [Related]
26. Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells.
Lovat PE; Oliverio S; Corazzari M; Rodolfo C; Ranalli M; Goranov B; Melino G; Redfern CP; Piacentini M
Cancer Res; 2003 Nov; 63(21):7310-3. PubMed ID: 14612528
[TBL] [Abstract][Full Text] [Related]
27. Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.
Appierto V; Cavadini E; Pergolizzi R; Cleris L; Lotan R; Canevari S; Formelli F
Br J Cancer; 2001 Jun; 84(11):1528-34. PubMed ID: 11384104
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic and apoptotic effects of prenylflavonoid artonin B in human acute lymphoblastic leukemia cells.
Lee CC; Lin CN; Jow GM
Acta Pharmacol Sin; 2006 Sep; 27(9):1165-74. PubMed ID: 16923337
[TBL] [Abstract][Full Text] [Related]
29. Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.
Sun SY; Li W; Yue P; Lippman SM; Hong WK; Lotan R
Cancer Res; 1999 May; 59(10):2493-8. PubMed ID: 10344763
[TBL] [Abstract][Full Text] [Related]
30. Anticancer effects of fenretinide in human medulloblastoma.
Damodar Reddy C; Guttapalli A; Adamson PC; Vemuri MC; O'Rourke D; Sutton LN; Phillips PC
Cancer Lett; 2006 Jan; 231(2):262-9. PubMed ID: 16399227
[TBL] [Abstract][Full Text] [Related]
31. HIF-1α-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia.
Liu XW; Su Y; Zhu H; Cao J; Ding WJ; Zhao YC; He QJ; Yang B
Pharmacol Res; 2010 Nov; 62(5):416-25. PubMed ID: 20637870
[TBL] [Abstract][Full Text] [Related]
32. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
Song MM; Makena MR; Hindle A; Koneru B; Nguyen TH; Verlekar DU; Cho H; Maurer BJ; Kang MH; Reynolds CP
Anticancer Drugs; 2019 Feb; 30(2):117-127. PubMed ID: 30272587
[TBL] [Abstract][Full Text] [Related]
34. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
[TBL] [Abstract][Full Text] [Related]
35. [Inhibitory effects on hepatocarcinoma and B16 melanoma cells by N-(4-hydrophenyl) retinamide].
Zhang L; Wu XZ
Shi Yan Sheng Wu Xue Bao; 2003 Dec; 36(6):421-7. PubMed ID: 14724932
[TBL] [Abstract][Full Text] [Related]
36. Fenretinide cytotoxicity is independent of both constitutive and pharmacologically modulated glutathione levels in pediatric acute lymphoblastic leukemia cells cultured at hypoxia.
Cooper JP; Bang S; Singh H; Williams SC; Kang MH
Pediatr Blood Cancer; 2012 Jun; 58(6):994-7. PubMed ID: 22532987
[TBL] [Abstract][Full Text] [Related]
37. The synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells.
Hsieh TC; Ng C; Wu JM
Biochem Mol Biol Int; 1995 Oct; 37(3):499-506. PubMed ID: 8595390
[TBL] [Abstract][Full Text] [Related]
38. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members.
Laane E; Panaretakis T; Pokrovskaja K; Buentke E; Corcoran M; Söderhäll S; Heyman M; Mazur J; Zhivotovsky B; Porwit A; Grandér D
Haematologica; 2007 Nov; 92(11):1460-9. PubMed ID: 18024393
[TBL] [Abstract][Full Text] [Related]
39. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase.
Wang H; Maurer BJ; Reynolds CP; Cabot MC
Cancer Res; 2001 Jul; 61(13):5102-5. PubMed ID: 11431347
[TBL] [Abstract][Full Text] [Related]
40. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.
Appierto V; Tiberio P; Villani MG; Cavadini E; Formelli F
Carcinogenesis; 2009 May; 30(5):824-31. PubMed ID: 19325135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
